Forkhead box (FOX) protein M1 (FOXM1) is a critical proliferation-associated transcription
factor (TF) that is aberrantly overexpressed in the majority of human cancers and has also …

The development of tumor therapeutic resistance is one of the important reasons for the
failure of antitumor therapy. Starting with multiple targets and multiple signaling pathways is …

Colorectal cancer (CRC) is one of the deadliest malignant tumors worldwide and its
prevalence is increasing in South Korea. The efficacy of combined treatment with natural …

The effectiveness of chemotherapeutic agents for hepatocellular carcinoma (HCC) is
unsatisfactory because of tumor heterogeneity, multidrug resistance, and poor target …

Purpose The oxygen and glucose deprivation-reoxygenation (OGDR) model is widely used
to evaluate ischemic stroke and cerebral ischemia-reperfusion (I/R) injury in vitro …

Both ursolic acid (UA) and sorafenib (Sora) have been generally utilized in cancer treatment,
and the combination of the two has also shown a good anti-tumor effect. However, single …

The treatment of cancer patients has been prohibited by chemoresistance. Doxorubicin
(DOX) is an anti-tumor compound disrupting proliferation and triggering cell cycle arrest via …

Triple negative breast cancer (TNBC) represents the most aggressive and heterogenous
disease, and combination therapy holds promising potential. Here, an enzyme-responsive …

Gastrointestinal malignancies are one of the major worldwide health concerns. In the
present review, we have assessed the plausible therapeutic implication of Ursolic Acid (UA) …

Triple negative breast cancer (TNBC) stands out as an aggressive and lethal subtype of
breast cancer. Despite being a mainstay in treatment, the efficacy of paclitaxel (PTX) …